FDA Medical Device · Z-2935-2026

Straumann Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim (Article 021.5314); implant, endosseous, root-form

Class II · Ongoing

Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim may inadvertently contain implants that are 12mm in length instead of 14mm as the labeling would suggest.

Affected lots / codes — check yours against thisUDI/DI 7630031707055, Lot ZVFV5

Recalling firm: Straumann USA LLC, Andover, MA
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 175 units
Distribution: US Nationwide distribution.
Recall initiated: July 16, 2026
Classified: August 11, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2935-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →